Marplan Tablet
Product Images NDC 72336-032

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Marplan (NDC 72336-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifsa Drugs Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Marplan (72336032 1)

MARPLAN 10 mg oral tablets label showing 100 tablets per container. The label includes the active ingredient isocarboxazid, prescription only status, and the manufacturer Lifsa Drugs LLC located in New Brunswick, NJ. The NDC number 72336-032 is also displayed.*

FDA Label Image

Lifsa Logo (Logo 1)

FDA Label Image

The Structural Formula For Marplan (isocarboxazid), A Monoamine Oxidase Inhibitor, Is Available For Oral Administration In 10-mg Tablets. Each Tablet Also Contains Lactose, Corn Starch, Povidone, D&c Red No. 27, Fd&c Yellow No. 6, And Magnesium Stearate. Chemically, Isocarboxazid Is 5-methyl-3-isoxazolecarboxylic Acid 2-benzylhydrazide. (Marplan 02)

Chemical structure of isocarboxazid, the active ingredient in MARPLAN 10 mg oral tablets. The diagram shows the molecular arrangement including rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.